Product · Trend Watch · Exosomes
P. 33 · REVIEWDeconstruct · Trend Watch
claims outpace evidence.
Cosmetic-grade exosomes at retail. The science is exciting in injectable / clinical settings — the topical evidence is thin, the regulatory ground is unsettled, and the dose claims are unverifiable. Save your money.
— § 01
— § 02
— § 03
There isn't one we can recommend on evidence grounds.
Treat it as an expensive humectant. Don't displace a proven retinoid / SPF / niacinamide for it.
If exosomes prove out in topical RCTs, formulas will be reformulated and prices will move. Today is too early.
— § 04
70⁄100
1/3 the price; real evidence base; daily-use safe.
68⁄100
Comparable 'modern serum' positioning; more conservative claims.
80⁄100
Hydrator + B5 in a vehicle backed by clinical research.
— § 05
In injectable post-procedure use — possibly. In a topical retail serum — very unlikely at present formulation standards. Don't conflate the two.
Products where marketing claims significantly exceed the topical evidence base. D doesn't mean 'will harm you' — it means 'won't deliver what's promised at this price'.
Not on a tolerability basis. The concern is opportunity cost — the money would do more elsewhere.
If the goal is anti-ageing: SPF + retinoid + niacinamide. If the goal is hydration: hyaluronic + ceramide moisturiser. The basics, dosed correctly.
— § 06